Home / XTNT : AMEX

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does XTNT make money? Does XTNT have pricing power? What's the Earnings Whisper? Will XTNT profit more as the business scales? What is XTNT's management track record? Is XTNT's current price justified?

Xtant Medical Holdings, Inc.

$0.35 -$0.40 (-53.71%)

AMEX · 11 Sep 2026 20:00 UTC

Previous Close

$0.34

Day Range

$0.32$0.35

Year Range

$0.27$0.95

Market Cap

48.5M

AVG Volume

1.2M

Trailing/Forward PE

-4.2/-

PEG ratio

0.07

Dividend Yield

Next Earnings Date

2026-11-10

Primary Exchange

New York Stock Exchange Arca

Revenue (USD)

XTNT Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	23.03M
26 Q1	20.88M
25 Q4	32.36M
25 Q3	33.26M
25 Q2	35.41M
25 Q1	32.9M
24 Q4	31.51M
24 Q3	27.94M
24 Q2	29.94M
24 Q1	27.87M

Net Income (USD)

XTNT Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-9.41M
26 Q1	-3.09M
25 Q4	57K
25 Q3	1.31M
25 Q2	3.55M
25 Q1	58K
24 Q4	-3.17M
24 Q3	-5.02M
24 Q2	-3.86M
24 Q1	-4.4M

Operating Income (USD)

XTNT Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-9.17M
26 Q1	-2.92M
25 Q4	-944K
25 Q3	2.54M
25 Q2	4.62M
25 Q1	1.06M
24 Q4	-1.88M
24 Q3	-3.78M
24 Q2	-2.95M
24 Q1	-3.47M

EBITDA (USD)

XTNT EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-8.29M
26 Q1	-1.93M
25 Q4	4.13M
25 Q3	3.63M
25 Q2	5.98M
25 Q1	2.15M
24 Q4	-862K
24 Q3	-2.69M
24 Q2	-1.83M
24 Q1	-2.49M

Cash Flows (USD)

XTNT Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-7.55M
26 Q1	-2.31M
25 Q4	4.99M
25 Q3	4.18M
25 Q2	910K
25 Q1	87K
24 Q4	-7K
24 Q3	-3.82M
24 Q2	-5.65M
24 Q1	-6.53M

EPS (USD)

XTNT EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0.07
26 Q1	-0.02
25 Q4	0
25 Q3	0.01
25 Q2	0.02
25 Q1	0
24 Q4	-0.02
24 Q3	-0.04
24 Q2	-0.03
24 Q1	-0.03

Expenses (USD)

XTNT Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	17.75M
26 Q1	15.09M
25 Q4	19.09M
25 Q3	19.88M
25 Q2	20.03M
25 Q1	20.37M
24 Q4	18.58M
24 Q3	22.19M
24 Q2	22.09M
24 Q1	21.55M

Cash & Debt (USD)

XTNT Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	9.87M
26 Q1	12.16M
25 Q4	17.05M
25 Q3	10.4M
25 Q2	6.92M
25 Q1	5.03M
24 Q4	6.2M
24 Q3	6.6M
24 Q2	5.38M
24 Q1	4.55M

Debt ratios

XTNT Debt ratios by quarter
Period	Debt ratios
26 Q2	-6.58
26 Q1	0.28
25 Q4	0.73
25 Q3	2.03
25 Q2	6.59
25 Q1	-9.05
24 Q4	-3.67
24 Q3	-3.3
24 Q2	12.57
24 Q1	6.72

Margins

XTNT Margins by quarter
Period	Margins
26 Q2	57.88%
26 Q1	57.32%
25 Q4	54.87%
25 Q3	66.13%
25 Q2	68.58%
25 Q1	61.52%
24 Q4	50.85%
24 Q3	58.37%
24 Q2	62.06%
24 Q1	62.07%

Return on Capital

XTNT Return on Capital by quarter
Period	Return on Capital
26 Q2	-23.52%
26 Q1	-6.36%
25 Q4	0.11%
25 Q3	2.6%
25 Q2	7.32%
25 Q1	0.13%
24 Q4	-7.37%
24 Q3	-10.99%
24 Q2	-8.58%
24 Q1	-9.23%

Shares Outstanding

XTNT Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	140.26M
26 Q1	139.83M
25 Q4	139.83M
25 Q3	139.31M
25 Q2	139.31M
25 Q1	143.34M
24 Q4	138.98M
24 Q3	135.1M
24 Q2	130.27M
24 Q1	130.2M

Book Value Per Share (USD)

XTNT Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	0.29
26 Q1	0.35
25 Q4	0.36
25 Q3	0.36
25 Q2	0.35
25 Q1	0.31
24 Q4	0.31
24 Q3	0.34
24 Q2	0.35
24 Q1	0.37

Total Assets (USD)

XTNT Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	79.67M
26 Q1	78M
25 Q4	94.14M
25 Q3	106.32M
25 Q2	103.48M
25 Q1	95.83M
24 Q4	93.84M
24 Q3	98.88M
24 Q2	95.58M
24 Q1	93.93M

Employee Count

XTNT Employee Count by quarter
Period	Employee Count
2025	151
2024	217
2023	207
2022	134
2021	116
2020	110
2019	141
2018	166
2017	174
2016	253

PE Ratio

XTNT PE Ratio by quarter
Period	PE Ratio
Aug 26	34.01
Jul 26	32.91
Jul 26	32.83
Jul 26	34.46
Jul 26	32.15
Jul 26	31.62
Jun 26	32.17
Jun 26	33.74
Jun 26	33.69
Jun 26	34.91
May 26	35.38
May 26	36.76
May 26	34.91
May 26	14.62
May 26	15.45
Apr 26	14.74
Apr 26	13.54
Apr 26	13.5
Apr 26	13.84
Mar 26	44
Mar 26	48.91
Mar 26	49.41
Mar 26	49.33
Feb 26	45.37
Feb 26	46.15
Feb 26	46.5
Feb 26	47.04
Jan 26	47.1
Jan 26	51.94
Jan 26	52.91
Jan 26	54.26
Jan 26	59.43
Dec 25	61.74
Dec 25	61.26
Dec 25	57.68
Dec 25	49.01
Nov 25	46.96
Nov 25	49.41
Nov 25	51.88
May 24	159.63
May 24	167.45
Apr 24	187.15
Apr 24	163.51
Apr 24	164.93
Apr 24	186.43
Mar 24	54.44
Mar 24	47.92
Mar 24	53.97
Mar 24	54.9
Mar 24	54.44
Feb 24	48.39
Feb 24	49.32
Feb 24	49.79
Feb 24	49.79
Jan 24	48.39
Jan 24	50.72
Jan 24	52.11
Jan 24	55.37
Dec 23	52.58
Dec 23	56.77
Dec 23	51.18
Dec 23	59.09
Dec 23	60.49
Nov 23	59.56
Nov 23	53.51

Free Cash Flow Yield

XTNT Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-1.44%
Sep 26	-1.32%
Aug 26	-1.29%
Aug 26	-1.53%
Aug 26	-1.63%
Aug 26	12.51%
Jul 26	12.93%
Jul 26	12.96%
Jul 26	12.35%
Jul 26	13.23%
Jul 26	13.46%
Jun 26	13.23%
Jun 26	12.61%
Jun 26	12.63%
Jun 26	12.19%
May 26	12.03%
May 26	11.58%
May 26	12.19%
May 26	13.98%
May 26	13.23%
Apr 26	13.87%
Apr 26	15.09%
Apr 26	15.14%
Apr 26	14.77%
Mar 26	6.71%
Mar 26	6.04%
Mar 26	5.98%
Mar 26	5.99%
Feb 26	6.51%
Feb 26	6.4%
Feb 26	6.35%
Feb 26	6.28%
Jan 26	6.27%
Jan 26	5.69%
Jan 26	5.58%
Jan 26	5.44%
Jan 26	4.97%
Dec 25	4.78%
Dec 25	4.82%
Dec 25	5.12%
Dec 25	6.03%
Nov 25	6.29%
Nov 25	5.98%
Nov 25	5.69%
Nov 25	-2.7%
Oct 25	-2.31%
Oct 25	-2.54%
Oct 25	-2.86%
Oct 25	-2.84%
Oct 25	-3.13%
Sep 25	-3.17%
Sep 25	-3.13%
Sep 25	-3.22%
Sep 25	-3.23%
Aug 25	-3.18%
Aug 25	-3.2%
Aug 25	-3.22%
Aug 25	-10.57%
Aug 25	-11.7%
Jul 25	-10.57%
Jul 25	-10.42%
Jul 25	-10.01%
Jul 25	-9.47%
Jun 25	-10.42%
Jun 25	-10.94%
Jun 25	-10.53%
Jun 25	-9.43%
May 25	-9.93%
May 25	-8.9%
May 25	-9.89%
May 25	-22.83%
May 25	-24.4%
Apr 25	-22.59%
Apr 25	-25.66%
Apr 25	-28.3%
Apr 25	-24.51%
Mar 25	-23.54%
Mar 25	-21.33%
Mar 25	-24%
Mar 25	-24.98%
Feb 25	-25.08%
Feb 25	-22.84%
Feb 25	-21.37%
Feb 25	-22.05%
Jan 25	-20.8%
Jan 25	-22.02%
Jan 25	-24.6%
Jan 25	-25.64%
Jan 25	-24.27%
Dec 24	-27.56%
Dec 24	-35.53%
Dec 24	-35.03%
Dec 24	-31.64%
Nov 24	-31.98%
Nov 24	-32.37%
Nov 24	-29.79%
Nov 24	-25.59%
Nov 24	-25.17%
Oct 24	-25.04%
Oct 24	-24.4%

Price to Sales

XTNT Price to Sales by quarter
Period	Price to Sales
Sep 26	0.44
Sep 26	0.48
Aug 26	0.49
Aug 26	0.42
Aug 26	0.39
Aug 26	0.51
Jul 26	0.49
Jul 26	0.49
Jul 26	0.52
Jul 26	0.48
Jul 26	0.47
Jun 26	0.48
Jun 26	0.51
Jun 26	0.5
Jun 26	0.52
May 26	0.53
May 26	0.55
May 26	0.52
May 26	0.54
May 26	0.57
Apr 26	0.55
Apr 26	0.5
Apr 26	0.5
Apr 26	0.51
Mar 26	0.58
Mar 26	0.64
Mar 26	0.65
Mar 26	0.65
Feb 26	0.6
Feb 26	0.61
Feb 26	0.61
Feb 26	0.62
Jan 26	0.62
Jan 26	0.68
Jan 26	0.7
Jan 26	0.71
Jan 26	0.78
Dec 25	0.81
Dec 25	0.81
Dec 25	0.76
Dec 25	0.64
Nov 25	0.62
Nov 25	0.65
Nov 25	0.68
Nov 25	0.82
Oct 25	0.96
Oct 25	0.87
Oct 25	0.77
Oct 25	0.78
Oct 25	0.71
Sep 25	0.7
Sep 25	0.71
Sep 25	0.69
Sep 25	0.69
Aug 25	0.7
Aug 25	0.69
Aug 25	0.69
Aug 25	0.73
Aug 25	0.66
Jul 25	0.73
Jul 25	0.74
Jul 25	0.77
Jul 25	0.81
Jun 25	0.74
Jun 25	0.7
Jun 25	0.73
Jun 25	0.81
May 25	0.77
May 25	0.86
May 25	0.78
May 25	0.6
May 25	0.56
Apr 25	0.6
Apr 25	0.53
Apr 25	0.48
Apr 25	0.56
Mar 25	0.58
Mar 25	0.64
Mar 25	0.57
Mar 25	0.55
Feb 25	0.61
Feb 25	0.66
Feb 25	0.71
Feb 25	0.69
Jan 25	0.73
Jan 25	0.69
Jan 25	0.62
Jan 25	0.59
Jan 25	0.63
Dec 24	0.55
Dec 24	0.43
Dec 24	0.43
Dec 24	0.48
Nov 24	0.47
Nov 24	0.47
Nov 24	0.51
Nov 24	0.62
Nov 24	0.63
Oct 24	0.63
Oct 24	0.65

EV/EBITDA

XTNT EV/EBITDA by quarter
Period	EV/EBITDA
Aug 26	5.53
Jul 26	5.36
Jul 26	5.35
Jul 26	5.6
Jul 26	5.25
Jul 26	5.16
Jun 26	5.25
Jun 26	5.49
Jun 26	5.49
Jun 26	5.67
May 26	5.75
May 26	5.96
May 26	5.67
May 26	5.31
May 26	5.57
Apr 26	5.34
Apr 26	4.97
Apr 26	4.96
Apr 26	5.06
Mar 26	9.1
Mar 26	9.89
Mar 26	9.97
Mar 26	9.95
Feb 26	9.32
Feb 26	9.44
Feb 26	9.5
Feb 26	9.59
Jan 26	9.59
Jan 26	10.37
Jan 26	10.53
Jan 26	10.74
Jan 26	11.58
Dec 25	11.95
Dec 25	11.87
Dec 25	11.29
Dec 25	9.9
Nov 25	9.57
Nov 25	9.97
Nov 25	10.36
Nov 25	29.49
Oct 25	33.35
Oct 25	30.96
Oct 25	28.19
Oct 25	28.36
Oct 25	26.37
Sep 25	26.1
Sep 25	26.36
Sep 25	25.79
Sep 25	25.76
Aug 25	26.03
Aug 25	25.91
Aug 25	25.81
Nov 24	41.62
Nov 24	42.1
Oct 24	42.26
Oct 24	43.04
Oct 24	45.85
Oct 24	47.4
Sep 24	49.61
Sep 24	51.41
Sep 24	44.44
Sep 24	43.81
Aug 24	53.48
Aug 24	49.29
Aug 24	47.07
Aug 24	46.9
Aug 24	30.93
Jul 24	33.42
Jul 24	33.5
Jul 24	32.38
Jul 24	30.5
Jun 24	29.49
Jun 24	31.3
Jun 24	33.86
Jun 24	32.66
May 24	32.74
May 24	33.86
May 24	32.74
May 24	24.26
May 24	25.28
Apr 24	27.84
Apr 24	24.77
Apr 24	24.95
Apr 24	27.74
Mar 24	29.34
Mar 24	26.14
Mar 24	29.11
Mar 24	29.57
Mar 24	29.34
Feb 24	26.37
Feb 24	26.83
Feb 24	27.05
Feb 24	27.05
Jan 24	26.37
Jan 24	27.51
Jan 24	28.2
Jan 24	29.8
Dec 23	28.43
Dec 23	30.49
Dec 23	27.74

Price/Operating Cashflow

XTNT Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	85.09
Sep 26	92.28
Aug 26	94.49
Aug 26	79.95
Aug 26	75.05
Aug 26	6.79
Jul 26	6.57
Jul 26	6.55
Jul 26	6.87
Jul 26	6.41
Jul 26	6.31
Jun 26	6.42
Jun 26	6.73
Jun 26	6.72
Jun 26	6.96
May 26	7.06
May 26	7.33
May 26	6.96
May 26	5.8
May 26	6.12
Apr 26	5.84
Apr 26	5.37
Apr 26	5.35
Apr 26	5.48
Mar 26	9.84
Mar 26	10.94
Mar 26	11.05
Mar 26	11.03
Feb 26	10.15
Feb 26	10.32
Feb 26	10.4
Feb 26	10.52
Jan 26	10.53
Jan 26	11.61
Jan 26	11.83
Jan 26	12.13
Jan 26	13.29
Dec 25	13.8
Dec 25	13.7
Dec 25	12.9
Dec 25	10.96
Nov 25	10.5
Nov 25	11.05
Nov 25	11.6
Nov 25	69.85
Oct 25	81.63
Oct 25	74.34
Oct 25	65.91
Oct 25	66.42
Oct 25	60.33
Sep 25	59.53
Sep 25	60.32
Sep 25	58.56
Sep 25	58.47
Aug 25	59.31
Aug 25	58.94
Aug 25	58.63
Jul 22	59.92
Jul 22	59.47
Jul 22	59.93
Jul 22	57.83
Jul 22	56.4
Jun 22	54.7
Jun 22	57.58
Jun 22	66.69
Jun 22	76.36
May 22	61.69
May 22	63.45
May 22	60.06
May 22	70.51
Apr 22	128.64
Apr 22	128.86
Apr 22	136.79
Apr 22	134.8
Apr 22	138.77
Mar 22	133.53
Mar 22	126.87
Mar 22	130.84
Mar 22	78.2
Feb 22	66.24
Feb 22	61.44
Feb 22	59.78
Feb 22	58.65
Jan 22	53.08
Jan 22	59.11
Jan 22	60.32
Jan 22	53.87
Dec 21	52.13
Dec 21	61.44
Dec 21	67.97
Dec 21	68.28
Dec 21	65.51
Nov 21	72.84
Nov 21	82.85
Nov 21	102.4
Nov 21	55.31
Oct 21	55.8
Oct 21	57.25
Oct 21	53.86
Oct 21	55.31

Price to Book

XTNT Price to Book by quarter
Period	Price to Book
Sep 26	1.21
Sep 26	1.31
Aug 26	1.35
Aug 26	1.14
Aug 26	1.07
Aug 26	1.28
Jul 26	1.24
Jul 26	1.23
Jul 26	1.29
Jul 26	1.21
Jul 26	1.19
Jun 26	1.21
Jun 26	1.27
Jun 26	1.27
Jun 26	1.31
May 26	1.33
May 26	1.38
May 26	1.31
May 26	1.43
May 26	1.51
Apr 26	1.44
Apr 26	1.32
Apr 26	1.32
Apr 26	1.35
Mar 26	1.53
Mar 26	1.7
Mar 26	1.72
Mar 26	1.71
Feb 26	1.58
Feb 26	1.6
Feb 26	1.62
Feb 26	1.63
Jan 26	1.64
Jan 26	1.81
Jan 26	1.84
Jan 26	1.89
Jan 26	2.07
Dec 25	2.15
Dec 25	2.13
Dec 25	2
Dec 25	1.7
Nov 25	1.63
Nov 25	1.72
Nov 25	1.8
Nov 25	2.16
Oct 25	2.53
Oct 25	2.3
Oct 25	2.04
Oct 25	2.06
Oct 25	1.87
Sep 25	1.84
Sep 25	1.87
Sep 25	1.81
Sep 25	1.81
Aug 25	1.84
Aug 25	1.82
Aug 25	1.81
Aug 25	2.03
Aug 25	1.83
Jul 25	2.03
Jul 25	2.05
Jul 25	2.14
Jul 25	2.26
Jun 25	2.05
Jun 25	1.96
Jun 25	2.03
Jun 25	2.27
May 25	2.16
May 25	2.41
May 25	2.16
May 25	1.63
May 25	1.53
Apr 25	1.65
Apr 25	1.45
Apr 25	1.32
Apr 25	1.52
Mar 25	1.58
Mar 25	1.75
Mar 25	1.55
Mar 25	1.49
Feb 25	1.51
Feb 25	1.65
Feb 25	1.77
Feb 25	1.71
Jan 25	1.82
Jan 25	1.72
Jan 25	1.54
Jan 25	1.47
Jan 25	1.56
Dec 24	1.37
Dec 24	1.06
Dec 24	1.08
Dec 24	1.19
Nov 24	1.18
Nov 24	1.17
Nov 24	1.27
Nov 24	1.52
Nov 24	1.55
Oct 24	1.55
Oct 24	1.6

No video analysis for this stock yet. Request one from our team.

News: XTNT

prnewswire.com · 27 Aug 2026

Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market

Partnership leverages BioHorizons' commercial network to broaden availability of Xtant's allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand as Prolifica™ BELGRADE, Mont., Aug. 27, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, announced an exclusive partnership with BioHorizons (a Henry Schein, Inc. company), whereby BioHorizons will distribute Xtant's allogeneic growth factor technology under the private brand Prolifica™ through its commercial network.

seekingalpha.com · 11 Aug 2026

Xtant Medical Holdings, Inc. (XTNT) Q2 2026 Earnings Call Transcript

prnewswire.com · 11 Aug 2026

Xtant Medical Reports Second Quarter 2026 Financial Results

Launched Trivium™ Shaped, an extension of its Trivium line of premium, next-generation demineralized bone matrix allograft for bone grafting procedures Company to host investor conference call and webcast today, August 11 th, at 8:30am ET BELGRADE, Mont., Aug. 11, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today reported financial and operating results for the second quarter ended June 30, 2026.

prnewswire.com · 6 Aug 2026

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

BELGRADE, Mont., Aug. 6, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the second quarter ended June 30, 2026, before the start of trading on Tuesday, August 11, 2026.

prnewswire.com · 4 Aug 2026

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

BELGRADE, Mont., Aug. 4, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that Sean Browne, CEO, Scott Neils, CFO, and Mark Schallenberger, COO, will be participating in the Canaccord Genuity 46th Annual Growth Conference, which is being held August 11-13, 2026, in Boston.